Cited by 244Infective Endocarditis Diagnosis and ManagementVenous Thromboembolism Diagnosis and ManagementStreptococcal Infections and Treatments

A randomized trial of aspirin on the risk of embolic events in patients with infective endocarditis

Open access
Chan, Kwan-Leung, Dumesnil, Jean G, Cujec, Bibiana, Sanfilippo, Anthony J, Jue, John, Turek, Michele A, Robinson, Trevor I, Moher, David·2003·Journal of the American College of Cardiology

Abstract

Objectives This study examined the effect of aspirin on the risk of embolic events in infective endocarditis (IE).Background Embolism is a major complication of IE, and studies in animal models have shown that platelet inhibition with aspirin can lead to more rapid vegetation resolution and a lower rate of embolic events.Methods We conducted a randomized, double-blinded, placebo-controlled trial of aspirin treatment (325 mg/day) for four weeks in patients with IE to test the hypothesis that the addition of aspirin would reduce the incidence of clinical systemic embolic events. Patients with perivalvular abscess were excluded. Serial cerebral computed tomograms and transesophageal echocardiograms were obtained in a subset of patients.Results During the four-year study period, 115 patients were enrolled: 60 assigned to aspirin and 55 assigned to placebo. Embolic events occurred in 17 patients (28.3%) on aspirin and 11 patients (20.0%) on placebo, with an odds ratio (OR) of 1.62 (95% confidence interval [CI] 0.68 to 3.86, p = 0.29). There was a trend toward a higher incidence of bleeding in the patients taking aspirin versus placebo (OR 1.92, 95% CI 0.76 to 4.86, p = 0.075). Development of new intracranial lesions was similar in both groups. Aspirin had no effect on vegetation resolution and valvular dysfunction.Conclusions In endocarditis patients already receiving antibiotic treatment, the addition of aspirin does not appear to reduce the risk of embolic events and is likely associated with an increased risk of bleeding. Aspirin is not indicated in the early management of patients with IE.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s0735-1097(03)00829-5

Cites

50 of 50 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Chan, K.-L., Dumesnil, J. G., Cujec, B., Sanfilippo, A. J., Jue, J., Turek, M. A., Robinson, T. I., & Moher, D.
Affiliations
  • University of Ottawa (CA)
  • Queen's University (CA)
  • University of British Columbia (CA)
  • University of Toronto (CA)
Corresponding author
Chan, Kwan-Leung
Venue
Journal of the American College of Cardiology
Publisher
Elsevier BV
Published
2003-09
Volume
42
Issue
5
Pages
775-780
ISSN
0735-1097 (ISSN-L)
OpenAlex
W2119369213
Cited by
244
References
50
Citations by year
2026: 5 · 2025: 11 · 2024: 6 · 2023: 15 · 2022: 7 · 2021: 11 · 2020: 21 · 2019: 9 · 2018: 3 · 2017: 6 · 2016: 14 · 2015: 11 · 2014: 12 · 2013: 13 · 2012: 14
FWCI
5.38
Type
journal article
Language
en
Open access
Locations
  • Journal of the American College of Cardiology (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Heart and Stroke Foundation of Canada
  • University of Ottawa
Topics
  • Health Sciences › Medicine › Epidemiology › Infective Endocarditis Diagnosis and Management
  • Health Sciences › Medicine › Internal Medicine › Venous Thromboembolism Diagnosis and Management
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Streptococcal Infections and Treatments
Keywords
aspirin, infective endocarditis, embolic events, systemic embolism, platelet aggregation inhibition, bleeding risk, intracranial lesions, valvular dysfunction, antibiotic therapy
MeSH terms
Aged, Anti-Bacterial Agents, Aspirin, Double-Blind Method, Drug Therapy, Combination, Embolism, Endocarditis, Bacterial, Female, Follow-Up Studies, Hemorrhage, Humans, Male, Middle Aged, Platelet Aggregation Inhibitors, Risk Factors, Severity of Illness Index, Tomography, X-Ray Computed, Incidence, Proportional Hazards Models, Odds Ratio, Single-Blind Method, Treatment Outcome, Echocardiography, Transesophageal

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review